Dr Susan Cleator

Dr Susan Cleator

BA, PhD, MRCP, FRCP

Consultant Clinical Oncologist

I trained at Oxford University and Hospitals, and undertook my oncology training at the Charing Cross, Hammersmith, Mount Vernon and The Royal Marsden Hospitals. During this period I also spent three years working full-time on her PhD project at the Institute of Cancer Research and Royal Marsden Hospital. This focused on defining molecular signatures of breast cancer that predict response to systemic treatment.

Specialism

  • Breast Cancer – Wide ranging experience and expertise including systemic therapy (chemotherapy, endocrine therapy, ‘biological’ therapies, emerging therapies) for early/ secondary breast cancer. This includes access to clinical trials.
  • Breast Radiotherapy, including emerging technologies
  • Colorectal Radiotherapy: Wide ranging experience and expertise including systemic therapy (chemotherapy, ‘biological’ therapies, emerging therapies) for early/ secondary colorectal cancer, including access to clinical trials
  • Rectal (pelvic) Radiotherapy.
  • Anal cancer: Special interest in this uncommon disease
  • Cyberknife Radiotherapy trained working within the HCA MDT framework

Current Roles

  • Chemotherapy Lead, Imperial Healthcare Trust (ICHT)
  • Breast Radiotherapy Lead, ICHT
  • Breast cancer Clinical Trials Lead, ICHT
  • Breast chemotherapy protocol lead, LOC
    Committee member Breast Cancer Pathway Group, LCA (body overseeing breast services delivery in South West London, including role in defining chemotherapy and radiotherapy LCA guidelines)
  • Previously member of Breast Cancer Studies Group (overseeing Breast Cancer National Research portfolio)

NHS Trust

  • Imperial College Healthcare NHS Trust

Research and Publications

Has published widely in International Journals, especially on biology of breast cancer and systemic treatment of early/late breast cancer and presents regularly at National meetings.

LOC 95 Harley Street